Acute myelogenous leukemia in pregnancy.
The experience with acute myelogenous leukemia treated with newer chemotherapeutic agents during pregnancy is limited. We have reported the case of a mother treated during the 24th week of pregnancy, and her infant delivered in the 29th week. At 14 months the infant is of low height and weight, but has a normal head circumference and developmental parameters.
D000328:Adult; D002585:Cesarean Section; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D012008:Recurrence
D003561:Cytarabine; D003630:Daunorubicin